These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18216720)

  • 1. Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding.
    Blanco G; Martínez C; Ladero JM; Garcia-Martin E; Taxonera C; Gamito FG; Diaz-Rubio M; Agundez JA
    Pharmacogenet Genomics; 2008 Jan; 18(1):37-43. PubMed ID: 18216720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
    Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
    Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2C9*3 Loss-of-Function Allele Is Associated With Acute Upper Gastrointestinal Bleeding Related to the Use of NSAIDs Other Than Aspirin.
    Carbonell N; Verstuyft C; Massard J; Letierce A; Cellier C; Deforges L; Saliba F; Delchier JC; Becquemont L
    Clin Pharmacol Ther; 2010 Jun; 87(6):693-8. PubMed ID: 20445534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
    García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
    Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C9 polymorphism in non-steroidal anti-inflammatory drugs-induced gastropathy.
    Ma J; Yang XY; Qiao L; Liang LQ; Chen MH
    J Dig Dis; 2008 May; 9(2):79-83. PubMed ID: 18419640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?
    Agúndez JA; García-Martín E; Martínez C
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):607-20. PubMed ID: 19422321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants.
    Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH
    Clin Pharmacol Ther; 2005 Jun; 77(6):479-85. PubMed ID: 15961979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use.
    Martínez C; Blanco G; Ladero JM; García-Martín E; Taxonera C; Gamito FG; Diaz-Rubio M; Agúndez JA
    Br J Pharmacol; 2004 Jan; 141(2):205-8. PubMed ID: 14707031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
    Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
    Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No modification of the beneficial effect of NSAIDs on colorectal cancer by CYP2C9 genotype.
    Siemes C; Eijgelsheim M; Dieleman JP; van Schaik RH; Uitterlinden AG; van Duijn CM; Hofman A; Coebergh JW; Stricker BH; Visser LE
    Neth J Med; 2009 Apr; 67(4):134-41. PubMed ID: 19581657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 CYP2C9 polymorphism and NSAID-related acute gastrointestinal bleeding.
    Agúndez JA; Martínez C; García-Martín E; Ladero JM
    Gastroenterology; 2007 Dec; 133(6):2071-2; author reply 2072-3. PubMed ID: 18054585
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonsteroidal antiinflammatory drugs and risk of gastrointestinal bleeding among patients on hemodialysis.
    Jankovic SM; Aleksic J; Rakovic S; Aleksic A; Stevanovic I; Stefanovic-Stoimenov N; Radosavljevic M; Kostic M; Tesic D; Petrovic B
    J Nephrol; 2009; 22(4):502-7. PubMed ID: 19662606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverticular bleeding: are nonsteroidal anti-inflammatory drugs risk factors for hemorrhage and can colonoscopy predict outcome for patients?
    Foutch PG
    Am J Gastroenterol; 1995 Oct; 90(10):1779-84. PubMed ID: 7572894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
    Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
    Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients.
    Hauta-Aho M; Tirkkonen T; Vahlberg T; Laine K
    Ann Med; 2009; 41(8):619-28. PubMed ID: 19711211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case study: nonsteroidal antiinflammatory drugs and gastrointestinal bleeding.
    Carson JL
    J Rheumatol Suppl; 1988 Oct; 17():24-7. PubMed ID: 3264583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotype.
    Kirchheiner J; Thomas S; Bauer S; Tomalik-Scharte D; Hering U; Doroshyenko O; Jetter A; Stehle S; Tsahuridu M; Meineke I; Brockmöller J; Fuhr U
    Clin Pharmacol Ther; 2006 Dec; 80(6):657-67. PubMed ID: 17178266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding. A case-control study.
    Bartle WR; Gupta AK; Lazor J
    Arch Intern Med; 1986 Dec; 146(12):2365-7. PubMed ID: 3490836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of CYP2C9 polymorphisms affecting warfarin metabolism in a large anticoagulant clinic cohort.
    Moridani M; Fu L; Selby R; Yun F; Sukovic T; Wong B; Cole DE
    Clin Biochem; 2006 Jun; 39(6):606-12. PubMed ID: 16630605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case-control study.
    Figueiras A; Estany-Gestal A; Aguirre C; Ruiz B; Vidal X; Carvajal A; Salado I; Salgado-Barreira A; Rodella L; Moretti U; Ibáñez L;
    Pharmacogenet Genomics; 2016 Feb; 26(2):66-73. PubMed ID: 26544900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.